Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Deferred Tax Assets / Liabilities ₹0.70 Cr₹0.60 Cr₹2.63 Cr₹3.58 Cr₹4.18 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA is ₹0.70 Cr based on Mar2023 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2023₹0.70 Cr
Mar2022₹0.60 Cr
Mar2021₹2.63 Cr
Mar2020₹3.58 Cr
Mar2019₹4.18 Cr

How is Deferred Tax Assets / Liabilities of BAL PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2023 ₹0.70 Cr
16.39
Mar2022 ₹0.60 Cr
-77.05
Mar2021 ₹2.63 Cr
-26.56
Mar2020 ₹3.58 Cr
-14.26
Mar2019 ₹4.18 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹163.1 Cr 3% 2.7% 22.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹112,990.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1% -2.4% 28.4% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

3%

2.7%

22.9%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses